Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saye Khoo

Showing results (231-240 of 282) with videos related to

Pageof 29
Sort By:
Plos One|July 21, 2021
Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIVDavide De Francesco, Xinzhu Wang, Laura Dickinson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 10, 2020
Enhanced and Timely Investigation of ARVs for Use in Pregnant WomenElaine J Abrams, Lynne M Mofenson, Anton Pozniak, et al.
Journal of Virus Eradication|August 3, 2016
Second European Round Table on the Future Management of HIV: 10-11 October 2014, Barcelona, SpainCasper Rokx, Douglas D Richman, Michaela Müller-Trutwin, et al.
The Pediatric Infectious Disease Journal|July 17, 2025
The Effects on the Growth of HIV-exposed Uninfected Infants of Initiating Dolutegravir-based Versus Efavirenz-based cART in Late Pregnancy (DolPHIN-2)Lisa Hagens, Lisanne A H Bevers, Thokozile R Malaba, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2012
Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adultsPauline Byakika-Kibwika, Mohammed Lamorde, Jonathan Mayito, et al.
Antiviral Therapy|September 6, 2008
Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medicationWolfgang Stöhr, David Back, David Dunn, et al.
The Journal of Antimicrobial Chemotherapy|November 10, 2009
Factors influencing lopinavir and atazanavir plasma concentrationWolfgang Stöhr, David Back, David Dunn, et al.
Plos One|August 25, 2021
Inflammatory pathways amongst people living with HIV in Malawi differ according to socioeconomic statusChristine Kelly, Willard Tinago, Dagmar Alber, et al.
Journal of Neurovirology|May 20, 2016
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemiaSam Nightingale, Anna Maria Geretti, Apostolos Beloukas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2022
Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionRichard FitzGerald, Laura Dickinson, Laura Else, et al.
Pageof 29

Showing results (231-240 of 282) with videos related to

Sort By:
Pageof 29
Plos One|July 21, 2021
Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIVDavide De Francesco, Xinzhu Wang, Laura Dickinson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 10, 2020
Enhanced and Timely Investigation of ARVs for Use in Pregnant WomenElaine J Abrams, Lynne M Mofenson, Anton Pozniak, et al.
Journal of Virus Eradication|August 3, 2016
Second European Round Table on the Future Management of HIV: 10-11 October 2014, Barcelona, SpainCasper Rokx, Douglas D Richman, Michaela Müller-Trutwin, et al.
The Pediatric Infectious Disease Journal|July 17, 2025
The Effects on the Growth of HIV-exposed Uninfected Infants of Initiating Dolutegravir-based Versus Efavirenz-based cART in Late Pregnancy (DolPHIN-2)Lisa Hagens, Lisanne A H Bevers, Thokozile R Malaba, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2012
Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adultsPauline Byakika-Kibwika, Mohammed Lamorde, Jonathan Mayito, et al.
Antiviral Therapy|September 6, 2008
Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medicationWolfgang Stöhr, David Back, David Dunn, et al.
The Journal of Antimicrobial Chemotherapy|November 10, 2009
Factors influencing lopinavir and atazanavir plasma concentrationWolfgang Stöhr, David Back, David Dunn, et al.
Plos One|August 25, 2021
Inflammatory pathways amongst people living with HIV in Malawi differ according to socioeconomic statusChristine Kelly, Willard Tinago, Dagmar Alber, et al.
Journal of Neurovirology|May 20, 2016
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemiaSam Nightingale, Anna Maria Geretti, Apostolos Beloukas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2022
Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionRichard FitzGerald, Laura Dickinson, Laura Else, et al.
Pageof 29